{"DataElement":{"publicId":"4207294","version":"1","preferredName":"Other T-Cell Receptor Chromosomal Translocation Cytogenetic Abnormality Specify","preferredDefinition":"The free text field describing a T-cell receptor translocation other than those previously specified.","longName":"4207293v1.0:2556910v1.0","context":"SWOG","contextVersion":"1","DataElementConcept":{"publicId":"4207293","version":"1","preferredName":"Other T-Cell Receptor Chromosomal Translocation Cytogenetic Abnormality","preferredDefinition":"A T-cell receptor translocation other than those previously specified.","longName":"4207291v1.0:2970756v1.0","context":"SWOG","contextVersion":"1","ObjectClass":{"publicId":"4207291","version":"1","preferredName":"Other T-Cell Receptor Chromosomal Translocation","preferredDefinition":"Different than the one(s) previously specified or mentioned.:Heterodimeric antigen receptors present on the surface of T-cells.  Two T-cell antigen receptors have been identified, consisting of heterodimeric 40-55 kD Ig-like alpha/beta or gamma/delta integral membrane glycoproteins.  Genes for TCR alpha, beta, gamma, and delta subunits are assembled during T-cell development by somatic rearrangement of germline gene segments, resembling B-cell Ig genes in their mechanisms of diversity generation and activation of expression.  Alpha/beta heterodimers are found on helper and cytotoxic T-cells and are specific for antigenic peptides presented by MHC gene products.  T-cells expressing gamma/delta heterodimers directly recognize proteins and non-proteinacious phospho-ligands.  T-cell receptors are non-covalently associated with CD3, forming the TCR-CD3 complex.  TCRs activate MAPKs and JNK1 through the CD3 antigens, the adaptor protein LAT, and tyrosine kinases LCK and ZAP70.  (from OMIM and NCI):A genetic exchange where a piece of one chromosome is transfered to another chromosome.","longName":"C17649:C17065:C3420","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T-Cell Receptor","conceptCode":"C17065","definition":"Heterodimeric antigen receptors present on the surface of T-cells.  Two T-cell antigen receptors have been identified, consisting of heterodimeric 40-55 kD Ig-like alpha/beta or gamma/delta integral membrane glycoproteins.  Genes for TCR alpha, beta, gamma, and delta subunits are assembled during T-cell development by somatic rearrangement of germline gene segments, resembling B-cell Ig genes in their mechanisms of diversity generation and activation of expression.  Alpha/beta heterodimers are found on helper and cytotoxic T-cells and are specific for antigenic peptides presented by MHC gene products.  T-cells expressing gamma/delta heterodimers directly recognize proteins and non-proteinacious phospho-ligands.  T-cell receptors are non-covalently associated with CD3, forming the TCR-CD3 complex.  TCRs activate MAPKs and JNK1 through the CD3 antigens, the adaptor protein LAT, and tyrosine kinases LCK and ZAP70.  (from OMIM and NCI)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Chromosomal Translocation","conceptCode":"C3420","definition":"A genetic exchange where a piece of one chromosome is transferred to another chromosome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F447658F-A815-F295-E040-BB89AD437C58","latestVersionIndicator":"Yes","beginDate":"2014-03-10","endDate":null,"createdBy":"KEARNSD","dateCreated":"2014-03-10","modifiedBy":"ONEDATA","dateModified":"2014-03-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2970756","version":"1","preferredName":"Cytogenetic Abnormality","preferredDefinition":"An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material.","longName":"C2950","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetic Abnormality","conceptCode":"C2950","definition":"An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B06B02F-1E7C-791E-E040-BB89AD433C19","latestVersionIndicator":"Yes","beginDate":"2009-12-18","endDate":null,"createdBy":"WHITES","dateCreated":"2009-12-18","modifiedBy":"ONEDATA","dateModified":"2009-12-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F447658F-A823-F295-E040-BB89AD437C58","latestVersionIndicator":"Yes","beginDate":"2014-03-10","endDate":null,"createdBy":"KEARNSD","dateCreated":"2014-03-10","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2556910","version":"1","preferredName":"Specify","preferredDefinition":"Be specific about something; define clearly.","longName":"SPEC","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2435024","version":"1","preferredName":"Drug or Chemical","preferredDefinition":"A category of organic or inorganic substances, elements, and isotopes used in research or for the prevention, diagnosis, and/or treatment of disease states. Includes biologically active substances that are either synthetically manufactured or endogenous substances extracted and processed to be reintroduced into an organism. Chemicals and drugs also include hazardous substances, and naturally occurring or synthetically produced substances required to maintain life.","longName":"C1908","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB04-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2390957","version":"1","preferredName":"Specify","preferredDefinition":"Specify; be specific about something; define clearly.","longName":"C25685","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FEED0CD5-44DE-6158-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-08-22","modifiedBy":"ONEDATA","dateModified":"2005-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"24FA6376-5316-2DE9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-29","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-12-19","modifiedBy":"REEVESD","dateModified":"2014-02-25","changeDescription":"10/20/08mn-added origin.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811952","version":"1","longName":"Cytogenetics","context":"CTEP"},{"publicId":"2811957","version":"1","longName":"Labs","context":"CTEP"}]}],"AlternateNames":[{"name":"OTHTCRTRANSP","type":"OID, SWOG","context":"SWOG"}],"ReferenceDocuments":[{"name":"specify","type":"Preferred Question Text","description":"specify","url":null,"context":"SWOG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F447658F-A834-F295-E040-BB89AD437C58","latestVersionIndicator":"Yes","beginDate":"2014-03-10","endDate":null,"createdBy":"KEARNSD","dateCreated":"2014-03-10","modifiedBy":"SCOTTM","dateModified":"2014-06-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}